Reviewing Gadsden Properties (OTCMKTS:GADS) & Helius Medical Technologies (NASDAQ:HSDT)

Helius Medical Technologies (NASDAQ:HSDT) and Gadsden Properties (OTCMKTS:GADS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Risk & Volatility

Helius Medical Technologies has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500. Comparatively, Gadsden Properties has a beta of -5.2, suggesting that its share price is 620% less volatile than the S&P 500.

Profitability

This table compares Helius Medical Technologies and Gadsden Properties’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Helius Medical Technologies	-1,487.54%	-258.06%	-113.47%
Gadsden Properties	N/A	N/A	N/A

Earnings & Valuation

This table compares Helius Medical Technologies and Gadsden Properties”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helius Medical Technologies	$640,000.00	2.83	-$8.85 million	($10.68)	-0.05
Gadsden Properties	N/A	N/A	N/A	N/A	N/A

Gadsden Properties has lower revenue, but higher earnings than Helius Medical Technologies.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Helius Medical Technologies and Gadsden Properties, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helius Medical Technologies	0	1	1	0	2.50
Gadsden Properties	0	0	0	0	N/A

Helius Medical Technologies presently has a consensus price target of $24.00, indicating a potential upside of 4,643.08%.

Institutional & Insider Ownership

18.6% of Helius Medical Technologies shares are held by institutional investors. 5.1% of Helius Medical Technologies shares are held by insiders. Comparatively, 5.0% of Gadsden Properties shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Helius Medical Technologies beats Gadsden Properties on 5 of the 8 factors compared between the two stocks.

About Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.